Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence

Fig. 1

Determination of stem cell markers and their Relationship with the Clinical Outcome of Gastric Cancer Patients. A Evaluation of 8 surface markers related to CSC in CD45− cells from 127 biopsies of gastric cancer patients. Error bars represent ± SD. B Plots of CD24+CD44+CD54+EpCAM+ (GCEP) cell percentage in patients with gastric cancer with metastasis and patients with localized gastric cancer. Error bars represent ± SD. ***p < 0.001. C Kaplan–Meier survival graph of patients with high (> 1.19) or low (< 1.19) %GCEP. No significant differences were observed between groups in the Log-rank test

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512